Moteur de recherche d’entreprises européennes

UK funding (547 786 £) : Une ressource de dépistage des récepteurs humains pour les interactions hôte-pathogène Ukri01/09/2023 UK Research and Innovation, Royaume Uni

Vue d’ensemble

Texte

Une ressource de dépistage des récepteurs humains pour les interactions hôte-pathogène

Abstract Infectious agents such as viruses, bacteria, fungi, and parasites cause disease in humans resulting in an enormous humanitarian burden and huge economic costs throughout the world. Direct interactions between the molecules displayed on the surface of our cells and pathogens are usually the first point of contact during an infection and are particularly important to understand how the infection will progress, and how cells of our immune systems will react. Crucially, understanding the molecules that are involved in the initial stages of infection can provide rational pathways to develop new therapeutic strategies and vaccines. Despite their medical importance, detecting interactions between host and pathogen cell surface molecules is challenging because of their specialised biochemical nature; consequently, studying this class of protein interaction remains an important, but relatively underexplored area of science. Over the last decade, we have developed specialised techniques to investigate these receptors and how they interact with other molecules. At the core of these methods is the creation of libraries containing several hundred different molecules that represent the pertinent external regions of human receptors that are much easier to work with experimentally. Our research has shown that these protein libraries can be used to answer important biological questions in many different fields of research but have been especially useful to detect host-pathogen interactions. So far, we have compiled a library that represents just under half of all the known human receptors representing a very valuable - although currently incomplete - resource. We know from frequent unsolicited requests from other scientists that there is a latent demand for access to this receptor library; however, producing these proteins is resource intensive so that supporting individual projects on an ad hoc basis becomes economically unviable. To address this, we are proposing to establish partnerships with UK research centres with world-leading expertise in pathogenic viruses, bacteria, fungi and parasites to create a centralised research infrastructure to identify host-pathogen interactions. To widen the overall utility of the library, we will obtain the missing molecules to make a comprehensive set of human receptors. We also want to ensure that this platform becomes a long-standing research infrastructure and so an important objective is to transition the platform into a self-sustaining entity that recovers running costs on a fee-for-service model. If realised, these partnerships would create a national research infrastructure in the UK that can be used by scientists from many different areas of biomedical research. Importantly, there are no similar resources that exist in the UK or the rest of the world that are openly accessible to academic research laboratories meaning this resource would immediately create research opportunities that would not otherwise exist. We envisage that this technical platform will facilitate basic discoveries that could improve the quality of peoples' lives including discovering human receptors for viruses and thereby assess their potential to cause future pandemics and identify targets for developing new vaccines.
Category Research Grant
Reference MR/X019705/1
Status Active
Funded period start 01/09/2023
Funded period end 31/08/2026
Funded value £547 786,00
Source https://gtr.ukri.org/projects?ref=MR%2FX019705%2F1

Participating Organisations

University of York
Technion - Israel Institute of Technology
Mayo Clinic
Wellspring
University of Glasgow
University Medical Center Utrecht (UMC)
THE PIRBRIGHT INSTITUTE
University of Murcia, Spain
University of Toronto
IMPERIAL COLLEGE LONDON
UNIVERSITY OF EXETER

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : University of York, Heslington, Royaume Uni.

Creative Commons License Les visualisations de "University of York - UK funding (547 786 £) : Une ressource de dépistage des récepteurs humains pour les interactions hôte-pathogène" sont mis à disposition par North Data et peuvent être réutilisées selon les termes de la licence Creative Commons CC-BY.